Original Research
Published on 28 Aug 2024
Network-based prediction of anti-cancer drug combinations
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418902
- 1,946 views
- 2 citations
Type at least 3 characters
2,866 articles
Original Research
Published on 27 Aug 2024
Identification of novel PHGDH inhibitors based on computational investigation: an all-in-one combination strategy to develop potential anti-cancer candidates
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1405350
- 2,254 views
Review
Published on 27 Aug 2024
Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446486
- 2,007 views
- 6 citations
Review
Published on 26 Aug 2024
DNA damage response-related ncRNAs as regulators of therapy resistance in cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1390300
- 2,331 views
- 2 citations
Original Research
Published on 23 Aug 2024
Comprehensive understanding of the adverse effects associated with temozolomide: a disproportionate analysis based on the FAERS database
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1437436
- 3,310 views
- 3 citations
Review
Published on 23 Aug 2024
Unraveling cancer progression pathways and phytochemical therapeutic strategies for its management
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1414790
- 3,566 views
- 7 citations
Original Research
Published on 22 Aug 2024
The role of the miR-30a-5p/BCL2L11 pathway in rosmarinic acid-induced apoptosis in MDA-MB-231-derived breast cancer stem-like cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1445034
- 1,744 views
- 2 citations
Original Research
Published on 21 Aug 2024
Combination of transcriptomic and proteomic approaches helps unravel the mechanisms of luteolin in inducing liver cancer cell death via targeting AKT1 and SRC
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1450847
- 1,819 views
- 3 citations
Original Research
Published on 21 Aug 2024
Comparative analysis of adverse event risks in breast cancer patients receiving pembrolizumab combined with paclitaxel versus paclitaxel monotherapy: insights from the FAERS database
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1345671
- 2,249 views
- 1 citation
Original Research
Published on 21 Aug 2024
Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1426912
- 1,696 views
- 1 citation
Original Research
Published on 21 Aug 2024
CAR-T therapy pulmonary adverse event profile: a pharmacovigilance study based on FAERS database (2017–2023)
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1434231
- 2,673 views
Original Research
Published on 20 Aug 2024
Radiological evaluation of response in patients with locally advanced/metastatic soft tissue sarcoma treated with trabectedin
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411707
- 1,209 views
Original Research
Published on 20 Aug 2024
Ocular adverse events associated with antibody-drug conjugates in oncology: a pharmacovigilance study based on FDA adverse event reporting system (FAERS)
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1425617
- 7,552 views
- 6 citations
Case Report
Published on 19 Aug 2024
Case report: outcome of anlotinib treatment in breast cancer patient with brain metastases
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1381478
- 1,707 views
- 1 citation
Correction
Published on 19 Aug 2024
Corrigendum: Anticancer applications of phytochemicals in gastric cancer: effects and molecular mechanism
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1405513
- 655 views
Original Research
Published on 19 Aug 2024
Study on antihepatocellular carcinoma effect of 6-shogaol and curcumin through network-based pharmacological and cellular assay
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1367417
- 2,168 views
- 2 citations